DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zelnorm (Tegaserod Maleate) - Summary

 

-- advertisement --

ZELNORM SUMMARY

Zelnorm® (tegaserod maleate) tablets contain tegaserod as the hydrogen maleate salt.

Zelnorm® (tegaserod maleate) is indicated for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.

The safety and effectiveness of Zelnorm in men with IBS with constipation have not been established.

Zelnorm® (tegaserod maleate) is indicated for the treatment of patients less than 65 years of age with chronic id-iopathic constipation. The effectiveness of Zelnorm in patients 65 years or older with chronic idiopathic constipation has not been established (see Geriatric Use).

The efficacy of Zelnorm for the treatment of IBS with constipation or chronic idiopathic constipation has not been studied beyond 12 weeks.

ZELNORM NEWS HIGHLIGHTS

Media Articles Related to Zelnorm (Tegaserod)

Zelnorm Has Serious Side Effects Alert
Source: MedicineNet tegaserod Specialty [2007.04.02]

IBS Drug Zelnorm Taken Off U.S. Market
Source: MedicineNet tegaserod Specialty [2007.03.30]

Experts Continue To Cite Bifantis As Promising Probiotic Treatment For Irritable Bowel Syndrome
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.08.01]

Salix Initiates Phase 3 For Rifaximin In Non-Constipation Irritable Bowel Syndrome
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.07.03]

Callisto Pharmaceuticals Opens Phase I Clinical Trial Of SP-304 To Treat Chronic Constipation And Irritable Bowel Syndrome
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.06.06]

more>>

Published Studies Related to Zelnorm (Tegaserod)

A randomized, controlled, double-blind trial of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation. [2008.08]

Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia: Results of Two Randomized, Controlled Trials. [2008.06.23]

A randomized, controlled, double-blind trial of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation. [2008.05.27]

Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial. [2008.05]

Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome. [2007.08]

more>>

Clinical Trials Related to Zelnorm (Tegaserod)

A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation [No longer available]

Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis [Terminated]

Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain. [Terminated]

The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. [Completed]

The Effects of Tegaserod Vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia [Withdrawn]

more>>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008